한국어 · English · 简体中文 · Русский · Bahasa Indonesia · ภาษาไทย · Tiếng Việt · 日本語

Approved ingredients

크릴오일등복합물(FlexPro MDⓇ)

크릴오일등복합물(FlexPro MDⓇ)

MFDS recognition no.2022-39
Approval routeNotified (고시형) — listed in MFDS public standards
Daily intake (as approved)462.0–462.0 mg/일
Approval holder주식회사 노바렉스

Approved wording (Korean original)

관절건강에 도움을 줄 수 있음
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.